Org50081

Esmirtazapine · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Org50081, covering 2014-06-30 to 2014-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) [Phase 3]

See pricing